On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.

Champignon Brands Inc. (CSE: SHRM) Leveraging New Research, Focusing on Overall Health for the Everyday Consumer

  • John Hopkins center for psychedelic research dedicated to discovering potential of mushrooms in support of overall health
  • Global functional-food market forecast to reach $34.3 billion by 2024; both reishi, cordyceps consumption expected to be in high demand
  • Distribution strategy involves e-commerce, social-media influencer marketing, product formulation and R&D agreement with Drip Coffee Social

Champignon Brands Inc. (CSE: SHRM) is a Canadian-based, research-driven company specializing in the formulation of mushroom-infused CPGs that promote holistic health and wellness. On March 2, 2020, the company saw its first day of trading on the Canadian Securities Exchange (CSE). Committed to sustainability, all SHRM products are organic, non-GMO and vegan certified.

SHRM offers a timely product line. The medical market is becoming more aware of the positive effects of mushrooms for mental health. In 2019, Johns Hopkins launched a center for psychedelic research backed by private funders (http://cnw.fm/1lTHD). At the center, a team of faculty neuroscientists, experimental psychologists, clinicians and postdoctoral scientists is dedicated to discovering the potential of psychedelics as medicine and in the support of overall health.

“The center’s establishment reflects a new era of research in therapeutics and the mind through studying this unique and remarkable class of pharmacological compounds,” said Roland Griffiths, PhD, the center’s director and professor of behavioral biology in the Department of Psychiatry and Behavioral Sciences and the Department of Neuroscience at the Johns Hopkins University School of Medicine. “In addition to studies on new therapeutics, we plan to investigate creativity and well-being in healthy volunteers that we hope will open up new ways to support human thriving.”

Alex Cohen, president of the Steven & Alexandra Cohen Foundation, which is covering the center’s operational expenses for the first five years, explained the foundation’s commitment. “We have to take braver and bolder steps if we want to help those suffering from chronic illness, addiction and mental health challenges,” she said. “By investing in the Johns Hopkins center, we are investing in the hope that researchers will keep proving the benefits of psychedelics – and people will have new ways to heal.”

The focus of John Hopkin’s studies will be on the affect psychedelics have on behavior, brain function, learning and memory, and the brain’s biology and mood. New therapies and the effectiveness of psilocybin are being explored for opioid addiction, Alzheimer’s disease, post-traumatic stress, post-treatment Lyme disease syndrome, anorexia nervosa and alcohol use related to depression.

The use of mushrooms in the health industry is growing in credibility in both scientific and financial sectors, and laws around the use of psilocybin mushrooms and their derivatives are changing. This progress is providing companies such as SHRM the opportunity to support mental health and develop new and improved treatments. The opportunities aren’t only medicinal, so while Champignon is preparing large-scale production for clinical settings, the company is also focused on retail opportunities in the health and wellness market.

The health-conscious consumer is seeking more options – and mushrooms may be the answer. The global functional-food market is forecast to reach $34.3 billion by 2024, and both reishi and cordyceps consumption is expected to experience exponential demand (http://cnw.fm/AYd8A). As the ‘shroom boom opens new possibilities in both medicine and functional food, SHRM has plans in place to effectively penetrate the market (http://cnw.fm/bo2Tl). The company’s distribution strategy involves e-commerce, social-media influencer marketing, and product formulation and R&D agreement with Drip Coffee Social.

The company’s product formulation and R&D agreement with Drip Coffee Social is designed to develop a ready-to-drink, cold-brew coffee line and hot beverages crafted in-house at Drip Coffee’s flagship location in Nanaimo, British Columbia. This new product line of coffees will be vegan, organic, and fair trade certified (http://cnw.fm/E5mjf).

In addition, Champignon’s flagship e-commerce store, VitalitySuperTeas.com, offers various mushroom-infused teas, “tea”-shirts, teacups, teapots and additional accessories. Those who are interested in being social media ambassadors are encouraged to reach out to sales@vitalitysuperteas.com.

For more information, visit the company’s website at www.ChampignonBrands.com

NOTE TO INVESTORS: The latest news and updates relating to SHRM are available in the company’s newsroom at http://cnw.fm/SHRM

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.cannabisnewswire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
303.498.7722 Office

CannabisNewsWire is part of the InvestorBrandNetwork.


Select A Month

Official NewsWire Relationships

Alternative Products Expo Benzinga Cannabis Capital Conference Cannabis Business Summit & Expo 2019 Cannabis Drinks Expo Cannabis World Congress & Business Exposition MjMicro Conference New England Cannabis Network O'Cannabiz Conference & Expo

CannabisNewsWire Currently Accepts



Bitcoin Cash

Bitcoin Cash

Doge Coin






USD Coin

USD Coin

Contact us: 303.498.7722